Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006675,
umls-concept:C0022671,
umls-concept:C0030518,
umls-concept:C0031603,
umls-concept:C0036536,
umls-concept:C0036537,
umls-concept:C0205178,
umls-concept:C0332208,
umls-concept:C0376387,
umls-concept:C0442027,
umls-concept:C0443252,
umls-concept:C0547047,
umls-concept:C1517945,
umls-concept:C1550025,
umls-concept:C2346689
|
pubmed:issue |
3
|
pubmed:dateCreated |
1995-8-24
|
pubmed:abstractText |
Persistent hyperparathyroidism and impaired tubular reabsorption of phosphate (P) are common after kidney transplantation. In order to assess the suppressibility of these abnormalities, we studied the effects of a single oral calcium (Ca) load (1 g) in 7 healthy subjects (HS) and in 14 normocalcemic long-term renal transplant recipients with good renal function (RT). In HS and RT, serum and urinary Ca were similar at baseline, and increased (p < 0.001) to the same extent after Ca ingestion. Serum parathyroid hormone (PTH) and nephrogenic cAMP (NcAMP) levels were higher at baseline in RT than HS (mean +/- SEM; respectively, PTH 7.8 +/- 0.8 vs. 3.5 +/- 0.6 pmol/l, p < 0.001, and NcAMP 24.8 +/- 2.3 vs. 13.9 +/- 2.3 nmol/l GFR, p < 0.01). After Ca, PTH (p < 0.001) and NcAMP (p < 0.01) decreased markedly in both RT and HS. Maximal changes in PTH and NcAMP were larger in RT than HS (PTH - 3.3 +/- 0.4 vs. -2.1 +/- 0.03 pmol/l, p < 0.01, and NcAMP -18.2 +/- 3.3 vs. -8.1 +/- 2.6 nmol/l GFR, p < 0.05). Although PTH levels remained significantly higher in RT than HS from baseline to the end of the study (p < 0.001), PTH decreased to the normal range in RT after Ca load. Moreover, NcAMP reached similar values in RT and HS after Ca (16.0 +/- 3.3 vs. 13.2 +/- 2.8 nmol/l GFR at the end of the survey, NS).(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-8095
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
238-44
|
pubmed:dateRevised |
2007-2-14
|
pubmed:meshHeading |
pubmed-meshheading:7618649-Administration, Oral,
pubmed-meshheading:7618649-Adult,
pubmed-meshheading:7618649-Calcium,
pubmed-meshheading:7618649-Case-Control Studies,
pubmed-meshheading:7618649-Cyclic AMP,
pubmed-meshheading:7618649-Female,
pubmed-meshheading:7618649-Humans,
pubmed-meshheading:7618649-Hyperparathyroidism, Secondary,
pubmed-meshheading:7618649-Kidney Transplantation,
pubmed-meshheading:7618649-Kidney Tubules,
pubmed-meshheading:7618649-Male,
pubmed-meshheading:7618649-Parathyroid Hormone,
pubmed-meshheading:7618649-Phosphates,
pubmed-meshheading:7618649-Postoperative Complications,
pubmed-meshheading:7618649-Time Factors
|
pubmed:year |
1995
|
pubmed:articleTitle |
Acute oral calcium load decreases parathyroid secretion and suppresses tubular phosphate loss in long-term renal transplant recipients.
|
pubmed:affiliation |
Explorations Fonctionnelles R?ales Métaboliques et Endocriniennes, Centre Hospitalier Universitaire, Bescançon, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|